Capvis AG has set up a EUR 230m continuation vehicle for the three remaining portfolio companies in Capvis Equity III, with Committed Advisors and Eurazeo co-leading the transaction.
Secondary buyout sees San-Francisco-based GP pre-empt auction for Italian generic drugmaker
GP makes series of promotions and appointments following GBP 2.5bn fundraising earlier this year
Enact III is more than three times the size of its predecessor fund, which closed on GBP 30m in 2019
Andre Retterath and Paul Klemm are existing team members, while Vincenzo Narciso joins from Px3 Partners